Literature DB >> 3346343

High-performance size-exclusion chromatographic determination of the potency of biosynthetic human growth hormone products.

R M Riggin1, C J Shaar, G K Dorulla, D S Lefeber, D J Miner.   

Abstract

A new high-performance size-exclusion chromatography method has been developed for the determination of potency of human growth hormone products. This method has been extensively validated and shown to correlate well with the hypophysectomized rat bioassay which has been used traditionally. The method is much more precise than the traditional bioassay and thus provides more reliable means of producing consistent biosynthetic human growth hormone batches.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3346343     DOI: 10.1016/s0021-9673(01)82190-7

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Concentrations of Intact Insulin Concurs With FDA and EMA Standards When Measured by HPLC in Different Parts of the Distribution Cold Chain.

Authors:  Alan Moses; Jesper Bjerrum; Morten Hach; Lars Holm Wæhrens; Anders Dyhr Toft
Journal:  J Diabetes Sci Technol       Date:  2018-06-28

2.  Nanofluidic device for continuous multiparameter quality assurance of biologics.

Authors:  Sung Hee Ko; Divya Chandra; Wei Ouyang; Taehong Kwon; Pankaj Karande; Jongyoon Han
Journal:  Nat Nanotechnol       Date:  2017-05-22       Impact factor: 39.213

3.  The effects of formulation variables on the stability of freeze-dried human growth hormone.

Authors:  M J Pikal; K M Dellerman; M L Roy; R M Riggin
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.